Overexpression of cell surface receptor c‐erbB2 of the tyrosine kinase family, altered K‐Ras oncogene, and irregularities in FGFR2/ErbB3/PI3 kinase pathway have been widely related to GC. This evidence concerns the gene ERBB3 and gastric cancer.